Belgium restricts use of J&J coronavirus vaccine to over-41s after death

Belgium Wednesday said it would no longer give people aged 41 and younger Johnson & Johnson’s COVID-19 vaccine after the death of a woman. The health ministry said the woman died on May 21 after being admitted to hospital with severe thrombosis and platelet deficiency — rare side effects the European Medicines Agency has previously said could be linked to the vaccine following analysis of cases in the U.S. Belgium has asked the EMA to evaluate whether the vaccine was linked to the death of the woman, who received the vaccine through her employer, reported Reuters.